Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine
Clinical trial NCT05846373 · COMPLETED
Trial details
- NCT number
- NCT05846373
- Sponsor
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-25
- Primary completion
- 2024-01-10
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.